Marshall Wace
ALT icon

Marshall Wace’s Altimmune ALT Stock Holding History

Marshall Wace’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4M Buy
4,017,901
+3,095,124
+335% +$13.1M 0.01% 880
2025
Q4 		$3.33M Buy
+922,777
New +$4.02M ﹤0.01% 1336
2025
Q3 		– Sell
-22,100
Closed -$85.5K – 2856
2025
Q2 		$85.5K Sell
22,100
-1,146,238
-98% -$6.2M ﹤0.01% 2561
2025
Q1 		$5.84M Buy
1,168,338
+1,102,821
+1,683% +$6.99M 0.01% 989
2024
Q4 		$472K Buy
+65,517
New +$501K ﹤0.01% 2051
2024
Q1 		– Sell
-86,132
Closed -$969K – 2404
2023
Q4 		$969K Sell
86,132
-1,712,608
-95% -$7.15M ﹤0.01% 1488
2023
Q3 		$4.68M Sell
1,798,740
-260,550
-13% -$748K 0.01% 890
2023
Q2 		$7.27M Buy
2,059,290
+462,160
+29% +$2.07M 0.01% 873
2023
Q1 		$6.74M Buy
1,597,130
+357,336
+29% +$4.25M 0.01% 859
2022
Q4 		$20.4M Buy
1,239,794
+140,880
+13% +$1.58M 0.05% 444
2022
Q3 		$14M Buy
1,098,914
+828,584
+307% +$12.2M 0.03% 634
2022
Q2 		$3.16M Buy
+270,330
New +$1.67M 0.01% 1686
2021
Q4 		– Sell
-478,923
Closed -$5.42M – 3828
2021
Q3 		$5.42M Sell
478,923
-449,793
-48% -$5.47M 0.02% 891
2021
Q2 		$9.15M Buy
+928,716
New +$12.7M 0.04% 524
2021
Q1 		– Sell
-31,049
Closed -$350K – 2435
2020
Q4 		$350K Buy
+31,049
New +$366K ﹤0.01% 1611

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace's ALT Position: Q1 2026 in Review

Marshall Wace increased its Altimmune (ALT) stake by 335% in Q1 2026, buying an estimated $13.1M and bringing the position to 4,017,901 shares worth $12.4M. The position accounts for 0.01% of the portfolio, ranked #880.

Marshall Wace first reported a position in ALT in Q4 2020 and has held it in 15 quarters since. The position peaked at $20.4M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Marshall Wace held 4,017,901 shares of Altimmune worth $12.4M as of Q1 2026.
  • Marshall Wace bought 3,095,124 Altimmune shares in Q1 2026, an estimated $13.1M.
  • Altimmune made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #880 holding.
  • Marshall Wace first reported a position in Altimmune in Q4 2020 and has held it in 15 quarters since.
  • Marshall Wace's Altimmune position peaked at $20.4M in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.